These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 15286541)

  • 1. Open randomized phase II trial of an extracorporeal endotoxin adsorber in suspected Gram-negative sepsis.
    Reinhart K; Meier-Hellmann A; Beale R; Forst H; Boehm D; Willatts S; Rothe KF; Adolph M; Hoffmann JE; Boehme M; Bredle DL;
    Crit Care Med; 2004 Aug; 32(8):1662-8. PubMed ID: 15286541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abdominal Septic Shock - Endotoxin Adsorption Treatment (ASSET) - endotoxin removal in abdominal and urogenital septic shock with the Alteco® LPS Adsorber: study protocol for a double-blinded, randomized placebo-controlled trial.
    Lipcsey M; Tenhunen J; Sjölin J; Frithiof R; Bendel S; Flaatten H; Kawati R; Kuitunen A; Tønnessen TI; Rubertsson S
    Trials; 2016 Dec; 17(1):587. PubMed ID: 27931259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new endotoxin adsorber: first clinical application.
    Ullrich H; Jakob W; Fröhlich D; Rothe G; Prasser C; Drobnik W; Taeger K; Meier-Hellmann A; Reinhart K; Zimmermann M; Schmitz G
    Ther Apher; 2001 Oct; 5(5):326-34. PubMed ID: 11778916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracorporeal endotoxin adsorption in septic patients--does it work?
    Grass G; Neugebauer EA
    Crit Care Med; 2004 Aug; 32(8):1792-3. PubMed ID: 15286564
    [No Abstract]   [Full Text] [Related]  

  • 5. A new endotoxin adsorption device in Gram-negative sepsis: use of immobilized albumin with the MATISSE adsorber.
    Staubach KH; Boehme M; Zimmermann M; Otto V
    Transfus Apher Sci; 2003 Aug; 29(1):93-8. PubMed ID: 12877899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Selective hemoperfusion in gram-negative severe sepsis of patients after cardiac surgery: a prospective randomized study].
    Iarustovskiĭ MB; Abramian MV; Popok ZV; Nazarova EI; Stupchenko OS; Popov DA; Pliushch MG
    Anesteziol Reanimatol; 2010; (5):60-5. PubMed ID: 21395144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Selective adsorption of endotoxin in the complex treatment of patients with severe sepsis].
    Khubutiia MSh; Abakumov MM; Aleksandrova IV; Reĭ SI; Il'inskiĭ ME; Khvatov VB; Borovkova NV; Pertsev AS; Zinkin VIu
    Anesteziol Reanimatol; 2010; (5):65-9. PubMed ID: 21395145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of endotoxin and cytokine adsorption haemofilter in septic acute kidney injury due to Gram-negative bacterial infection.
    Shum HP; Chan KC; Kwan MC; Yan WW
    Hong Kong Med J; 2013 Dec; 19(6):491-7. PubMed ID: 23650198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Open randomized phase II trial of an extracorporeal endotoxin adsorber in suspected gram-negative sepsis.
    Balogun RA
    Crit Care Med; 2005 Feb; 33(2):461-2. PubMed ID: 15699862
    [No Abstract]   [Full Text] [Related]  

  • 10. A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group.
    Bone RC; Balk RA; Fein AM; Perl TM; Wenzel RP; Reines HD; Quenzer RW; Iberti TJ; Macintyre N; Schein RM
    Crit Care Med; 1995 Jun; 23(6):994-1006. PubMed ID: 7774238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Polymyxin-B direct hemoperfusion (PMX-DHP) in gram negative sepsis].
    Perego AF; Morabito S; Graziani G; Casella GP; Parodi O
    G Ital Nefrol; 2006; 23 Suppl 36():S94-102. PubMed ID: 17068736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endotoxin Elimination in Patients with Septic Shock: An Observation Study.
    Adamik B; Zielinski S; Smiechowicz J; Kübler A
    Arch Immunol Ther Exp (Warsz); 2015 Dec; 63(6):475-83. PubMed ID: 26093653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PMX endotoxin removal in the clinical practice: results from the EUPHAS trial.
    Antonelli M; Fumagalli R; Cruz DN; Brienza N; Giunta F
    Contrib Nephrol; 2010; 167():83-90. PubMed ID: 20519902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of a novel endotoxin adsorber polyvinylidene fluoride fiber immobilized with (L)-serine ligand on septic pigs.
    Gao JP; Huang M; Li N; Wang PF; Chen HL; Xu QP
    J Zhejiang Univ Sci B; 2011 Apr; 12(4):264-72. PubMed ID: 21462381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endotoxin adsortion as adjuvant therapy in gram negative severe sepsis].
    Candel FJ; Martínez-Sagasti F; Borges M; Maseda E; Herrera-Gutiérrez M; Garnacho-Montero J; Maynar FJ; Zaragoza R; Mensa J; Azanza JR
    Rev Esp Quimioter; 2010 Sep; 23(3):115-21. PubMed ID: 20844841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial.
    Cruz DN; Antonelli M; Fumagalli R; Foltran F; Brienza N; Donati A; Malcangi V; Petrini F; Volta G; Bobbio Pallavicini FM; Rottoli F; Giunta F; Ronco C
    JAMA; 2009 Jun; 301(23):2445-52. PubMed ID: 19531784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The first experience in using selective sorbents in complex intensive care of patients with infectious and septic complications after cardiac surgery].
    Iarustovskiĭ MB; Abramian MV; Popok ZV; Nazarova EI; Stupchenko OS; Popov DA; Pliushch MG; Samsonova NN
    Anesteziol Reanimatol; 2008; (6):49-55. PubMed ID: 19227295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endotoxin Removal in Septic Shock with the Alteco LPS Adsorber Was Safe But Showed no Benefit Compared to Placebo in the Double-Blind Randomized Controlled Trial-the Asset Study.
    Lipcsey M; Tenhunen J; Pischke SE; Kuitunen A; Flaatten H; De Geer L; Sjölin J; Frithiof R; Chew MS; Bendel S; Kawati R; Larsson A; Mollnes TE; Tønnessen TI; Rubertsson S
    Shock; 2020 Aug; 54(2):224-231. PubMed ID: 31880758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confirmatory platelet-activating factor receptor antagonist trial in patients with severe gram-negative bacterial sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. BN 52021 Sepsis Investigator Group.
    Dhainaut JF; Tenaillon A; Hemmer M; Damas P; Le Tulzo Y; Radermacher P; Schaller MD; Sollet JP; Wolff M; Holzapfel L; Zeni F; Vedrinne JM; de Vathaire F; Gourlay ML; Guinot P; Mira JP
    Crit Care Med; 1998 Dec; 26(12):1963-71. PubMed ID: 9875905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of correlation between inflammatory parameters and severity of sepsis caused by bacterial bloodstream infection in septic patients].
    Zhao L; Zang X; Chen W; Sheng B; Gu X; Zhang J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Jun; 27(6):448-53. PubMed ID: 26049182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.